JPRN-UMIN000006525已完成2 期
Phase2 Trial of Carboplatin-Paclitaxel bi-weekly and Bevacizumab combination therapy for Elderly Patients With Nonsquamous Non-Small-Cell Lung Cancer - Phase2 Trial of Carboplatin-Paclitaxel bi-weekly and Bevacizumab combination therapy for Elderly Patients With Nonsquamous Non-Small-Cell Lung Cancer
Shimane University, School of Medicine0 个研究点目标入组 23 人开始时间: 2011年10月12日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Squamous cell carcinoma. 2) Patients with double cancer. 3) Plan on Concurrent Radiotherapy. 4) Patients with active severe infections. 5) Patients with brain metastasis. 6) History of hemoptysis. 7) Cavity in tumor. 8) Have a bleeding diathesis. 9) Concurrent use of steroid therapy. 10) Use of flucytosine. 11) History of thrombosis. 12) Patients with massive uncontrolled pleural or pericardial effusion ,or ascites. 13) Patients with active severe comorbidity disease. 14) Patients with serious drug allergic reactions. 15) Patients with active concomitant pregnancy. 16) Inappropriate patients for this study judged by the physicians.
研究者
相似试验
招募中
不适用
Phase II study of carboplatin, weekly paclitaxel and bevacizumab for advanced non-squamous cell, non-small-cell lung cancer with idiopathic interstitial pneumoniaadvanced non-squamous cell, non-small-cell lung cancer with idiopathic interstitial pneumoniaJPRN-UMIN000018322IP lung cancer study group35
已完成
2 期
Phase II study of Carboplatin, weekly Paclitaxel and Bevacizumab in elderly patients with advanced non-squamous non-small-cell lung cancer (NEJ 016)non-small cell lung cancerJPRN-UMIN000006622orth East Japan Study Group36
进行中（未招募）
不适用
A phase II trial of carboplatin and paclitaxel compared with carboplatin or gemcitabine paclitaxel induction followed by carboplatin/paclitaxel/gemcitabine in patients with suboptimally resected stage III or IV ovarian carcinoma - NDEUCTR2006-000126-31-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
已完成
不适用
Phase II study of carboplatin plus weekly paclitaxel for advanced squamous cell lung cancer with idiopathic interstitial pneumoniaJPRN-UMIN000018248IP lung cancer study group40
招募中
2 期
Phase II study of Weekly Paclitaxel+Weekly Carboplatin for Platinum/Taxan sensitive recurrent mullerian carcinomaJPRN-UMIN000003476Japan Kanto Tumor Board(JKTB)65